BioPacific Angels


BioPacific Investors is...
An angel investment group created to leverage cross-pacific business opportunities
by investing in early stage life science and healthcare companies with an Asia connection
  • Provide a funding source to emerging life science and healthcare companies that have a business focus on China/Asia and are pre-venture capital or do not fit traditional funding models
  • Identify and present well-vetted cross-border investment opportunities to the membership
  • Simplify the investment vehicle for members, companies and follow-on investors
  • Contribute business, scientific and regional expertise to companies to improve probability for success 
  • Founded and managed by angel investors and life science executives with broad cross-pacific experience
  • Non-profit organization (501(c)(6)) with investments made through a for-profit LLC
  • Operations funded by sponsors including Dorsey & Whitney, ChinaBio and others, and membership dues
  • No override or management fees; all of investors' money goes to the companies
  • All work performed by members on a pro bono basis except Managing Director
  • 60+ members in US, China, Japan, Korea, India, Singapore & Australia; offices in Palo Alto & Shanghai
  • Individual members must be accredited investors with business or scientific expertise in life sciences
  • Affiliate members include VC/PE firms and multinational corporations with a focus on life science
  • Members must be recommended by two existing members and be accepted by Membership Committee
  • Minimum investment requirement of $25,000/year; $2,000/year individual membership fee
Investment Opportunities
  • Broad life science focus: pharma/biotech, medical devices, diagnostics, digital health & healthcare services
  • Robust deal flow of 350+ deals/yr from founders, members, sponsors, venture capitalists and universities
  • Screening Committee reviews all investment opportunities and selects those to present to membership
  • No charge to submit business plans or present to membership (if selected)
  • Five member investment meetings/year with two presenting companies (30 min. each)
  • Mettings held in Shanghai and Palo Alto, with Webex available to participants in other locations
  • Targeted investment range of $250,000 to $1 million per investment; potential to syndicate larger deals
  • Companies must have or plan to have a presence in China or elsewhere in Asia
Contact Information
For membership or sponsorship information:                                BioPacific Investors, Inc.
       Ann Gaddy, Managing Director                                            Palo Alto, San Diego, Shanghai                                  
See Dorsey's video from the ChinaBio Partnering Forum 2015: 
The top seven challenges in structuring China-related transactions
     Speaker: Peter Corne, LLM – Dorsey & Whitney LLP
         Frank S. Hong, JD – Dorsey & Whitney LLP 

ChinaBio Group is a sponsor of BioPacific Investors, but has no legal or financial interest and does not benefit from investments made by any other party.